A comparison study of monoexponential and fractional order calculus diffusion models and 18F-FDG PET in differentiating benign and malignant solitary pulmonary lesions and their pathological types

被引:5
|
作者
Luo, Yu [1 ,2 ,3 ]
Jiang, Han [2 ,4 ]
Meng, Nan [1 ,2 ,3 ]
Huang, Zhun [2 ,5 ]
Li, Ziqiang [2 ,4 ]
Feng, Pengyang [2 ,5 ]
Fang, Ting [1 ,2 ,3 ]
Fu, Fangfang [1 ,2 ]
Yuan, Jianmin [6 ]
Wang, Zhe [6 ]
Yang, Yang [7 ]
Wang, Meiyun [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Dept Med Imaging, Zhengzhou, Peoples R China
[2] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Acad Med Sci, Zhengzhou, Peoples R China
[4] Xinxiang Med Univ, Dept Med Imaging, Xinxiang, Henan, Peoples R China
[5] Henan Univ, Peoples Hosp, Dept Med Imaging, Zhengzhou, Peoples R China
[6] United Imaging Healthcare Grp, Cent Res Inst, Shanghai, Peoples R China
[7] Beijing United Imaging Res Inst Intelligent Imagin, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
solitary pulmonary lesions; lung cancer; PET; MR; diffusion-weighted imaging; fractional order calculus; differentiation diagnosis; CELL LUNG-CANCER; WEIGHTED MRI; ANOMALOUS DIFFUSION; TUMOR; KI-67; COEFFICIENT; TOMOGRAPHY;
D O I
10.3389/fonc.2022.907860
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveTo evaluate the application value of monoexponential, fractional order calculus (FROC) diffusion models and PET imaging to distinguish between benign and malignant solitary pulmonary lesions (SPLs) and malignant SPLs with different pathological types and explore the correlation between each parameter and Ki67 expression. MethodsA total of 112 patients were enrolled in this study. Prior to treatment, all patients underwent a dedicated thoracic F-18-FDG PET/MR examination. Five parameters [including apparent diffusion coefficient (ADC) derived from the monoexponential model; diffusion coefficient (D), a microstructural quantity (mu), and fractional order parameter (beta) derived from the FROC model and maximum standardized uptake value (SUVmax) derived from PET] were compared between benign and malignant SPLs and different pathological types of malignant SPLs. Independent sample t test, Mann-Whitney U test, DeLong test and receiver operating characteristic (ROC) curve analysis were used for statistical evaluation. Pearson correlation analysis was used to calculate the correlations between Ki-67 and ADC, D, mu, beta, and SUVmax. ResultsThe ADC and D values were significantly higher and the mu and SUVmax values were significantly lower in the benign group [1.57 (1.37, 2.05) mu m(2)/ms, 1.59 (1.52, 1.72) mu m(2)/ms, 5.06 (3.76, 5.66) mu m, 5.15 +/- 2.60] than in the malignant group [1.32 (1.03, 1.51) mu m(2)/ms, 1.43 (1.29, 1.52) mu m(2)/ms, 7.06 (5.87, 9.45) mu m, 9.85 +/- 4.95]. The ADC, D and beta values were significantly lower and the mu and SUVmax values were significantly higher in the squamous cell carcinoma (SCC) group [1.29 (0.66, 1.42) mu m(2)/ms, 1.32 (1.02, 1.42) mu m(2)/ms, 0.63 +/- 0.10, 9.40 (7.76, 15.38) mu m, 11.70 +/- 5.98] than in the adenocarcinoma (AC) group [1.40 (1.28, 1.67) mu m(2)/ms, 1.52 (1.44, 1.64) mu m(2)/ms, 0.70 +/- 0.10, 5.99 (4.54, 6.87) mu m, 8.76 +/- 4.18]. ROC curve analysis showed that for a single parameter, mu exhibited the best AUC value in discriminating between benign and malignant SPLs groups and AC and SCC groups (AUC = 0.824 and 0.911, respectively). Importantly, the combination of monoexponential, FROC models and PET imaging can further improve diagnostic performance (AUC = 0.872 and 0.922, respectively). The Pearson correlation analysis showed that Ki67 was positively correlated with mu value and negatively correlated with ADC and D values (r = 0.402, -0.346, -0.450, respectively). ConclusionThe parameters D and mu derived from the FROC model were superior to ADC and SUVmax in distinguishing benign from malignant SPLs and adenocarcinoma from squamous cell carcinoma, in addition, the combination of multiple parameters can further improve diagnostic performance. The non-Gaussian FROC diffusion model is expected to become a noninvasive quantitative imaging technique for identifying SPLs.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis
    Jia, Yuzhu
    Gong, Wanfeng
    Zhang, Zhiping
    Tu, Gaofeng
    Li, Jiapeng
    Xiong, Fanfan
    Hou, Hongtao
    Zhang, Yunyi
    Wu, Meiqian
    Zhang, Liping
    JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 2082 - 2098
  • [22] Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions
    Roedl, Johannes B.
    Colen, Rivka R.
    King, Kevin
    Fischman, Alan J.
    Mueller, Peter R.
    Blake, Michael A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 191 (02) : 515 - 521
  • [23] The role of F-18 FDG PET/CT in differentiating benign from malignant pulmonary masses and accompanying lymph nodes
    Cengiz, Arzu
    Aydin, Funda
    Sipahi, Murat
    Dertsiz, Levent
    Ozbilim, Gulay
    Bozkurt, Selen
    Gungor, Firat
    Boz, Adil
    Erkilic, Metin
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2018, 66 (02): : 130 - 135
  • [24] Dynamic contrast-enhanced MRI versus 18F-FDG PET/CT: Which is better in differentiation between malignant and benign solitary pulmonary nodules?
    Feng, Feng
    Qiang, Fulin
    Shen, Aijun
    Shi, Donghui
    Fu, Aiyan
    Li, Haiming
    Zhang, Mingzhu
    Xia, Ganlin
    Cao, Peng
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (01) : 21 - 30
  • [25] Diagnostic Performance of Machine Learning Models Based on 18F-FDG PET/CT Radiomic Features in the Classification of Solitary Pulmonary Nodules
    Salihoglu, Yavuz Sami
    Erdemir, Rabiye Uslu
    Puren, Busra Aydur
    Ozdemir, Semra
    Uyulan, Caglar
    Erguzel, Turker Tekin
    Tekin, Huseyin Ozan
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2022, 31 (02) : 82 - 88
  • [26] Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations
    Parghane, Rahul V.
    Basu, Sandip
    SEMINARS IN NUCLEAR MEDICINE, 2017, 47 (04) : 373 - 391
  • [27] Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions
    Eiber, Matthias
    Takei, Toshiki
    Souvatzoglou, Michael
    Mayerhoefer, Marius E.
    Fuerst, Sebastian
    Gaertner, Florian C.
    Loeffelbein, Denys J.
    Rummeny, Ernst J.
    Ziegler, Sibylle I.
    Schwaiger, Markus
    Beer, Ambros J.
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) : 191 - 197
  • [28] A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions
    Xie, Fei
    Zheng, Kun
    Liu, Linwen
    Jin, Xiaona
    Fu, Lilan
    Zhu, Zhaohui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases
    Huang, Yu-Erh
    Huang, Yu-Jie
    Ko, Mary
    Hsu, Chien-Chin
    Chen, Chih-Feng
    ANNALS OF NUCLEAR MEDICINE, 2016, 30 (09) : 652 - 658
  • [30] Diagnostic performance of diffusion-weighted imaging versus 18F-FDG PET/CT in differentiating pulmonary lesions: an updated meta-analysis of comparative studies
    Jieqiong Liu
    Xiaoying Xia
    Qiao Zou
    Xiaobin Xie
    Yongxia Lei
    Qi Wan
    Xinchun Li
    BMC Medical Imaging, 23